NYSEARCA:XPHSPDR S&P Pharmaceuticals ETF Stock Price, Forecast & News

SPDR S&P Pharmaceuticals ETF's stock was trading at $37.41 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, XPH shares have increased by 15.8% and is now trading at $43.33. View which stocks have been most impacted by Coronavirus.

SPDR S&P Pharmaceuticals ETF declared a quarterly dividend on Monday, December 23rd. Stockholders of record on Tuesday, December 24th will be paid a dividend of $0.0711 per share on Friday, December 27th. This represents a $0.28 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date is Monday, December 23rd. This is an increase from SPDR S&P Pharmaceuticals ETF's previous quarterly dividend of $0.07. View SPDR S&P Pharmaceuticals ETF's dividend history.

News headlines about XPH stock have been trending neutral this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SPDR S&P Pharmaceuticals ETF earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about SPDR S&P Pharmaceuticals ETF.

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Pharmaceuticals ETF investors own include Pfizer (PFE), Bank of America (BAC), Target (TGT), Broadcom (AVGO), ConocoPhillips (COP), Chevron (CVX), Docusign (DOCU), SPDR Gold Shares (GLD), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XPH."

SPDR S&P Pharmaceuticals ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.78%).

XPH stock was acquired by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc..

Shares of XPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of XPH stock can currently be purchased for approximately $43.33.

SPDR S&P Pharmaceuticals ETF has a market capitalization of $236.15 million.

The official website for SPDR S&P Pharmaceuticals ETF is www.spdrs.com.

SPDR S&P Pharmaceuticals ETF's mailing address is State Street Financial Center One Lincoln Street, BOSTON, MA 02111, United States. The company can be reached via phone at +1-617-6644738.